Product Name: (2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone CAS NO:915095-86-2
Chemical & Physical Properties:
Appearance: white powder
Boiling Point:414.6℃ at 760 mmHg
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone is an intermediate in the synthesis of empagliflozin. Empagliflozin is a type 2 sodium-glucose cotransporter inhibitor jointly developed by Boehringer Ingelheim and Eli Lilly. SGLT-2 inhibitor is a new type of hypoglycemic agent, mainly by inhibiting the expression of SGLT-2 in the kidney, reducing the kidney's reabsorption of glucose, increasing the excretion of glucose in urine, thereby reducing the plasma glucose level, its hypoglycemic effect is not Depends on β cell function and insulin resistance.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.